切换至 "中华医学电子期刊资源库"

中华腔镜外科杂志(电子版) ›› 2026, Vol. 19 ›› Issue (04) : 248 -253. doi: 10.3877/cma.j.issn.1674-6899.2026.04.010

综述

子宫腺肌病保守性手术的现状与未来展望
虞意1, 毛惠2, 虞绮雯1, 刘驰1, 祖逸峥1, 陈婉莹1, 魏炜炜1, 陈继明1,†()   
  1. 1213000 南京医科大学第三附属医院,常州市第二人民医院妇产科
    2663099 文山壮族苗族自治州人民医院妇产科
  • 收稿日期:2026-07-17 出版日期:2026-08-30
  • 通信作者: 陈继明
  • 基金资助:
    中国医药卫生事业发展基金会资助课题(BJ2023YCPYJH003); 常州市"十四五"卫生健康高层次人才培养工程(2022CZBJ074); 江苏省妇幼健康科研项目(F202138); 常州市卫健委科技项目重大项目(ZD202314)

Current status and future perspectives of conservative surgery for adenomyosis

Yi Yu1, Hui Mao2, Qiwen Yu1, Chi Liu1, Yizheng Zu1, Wanying Chen1, Weiwei Wei1, Jiming Chen1,†()   

  1. 1Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Second People′s Hospital, 213000, China
    2Department of Obstetrics and Gynecology, Wenshan Zhuang and Miao Autonomous Prefecture Peoples Hospital, 663099, China
  • Received:2026-07-17 Published:2026-08-30
  • Corresponding author: Jiming Chen
引用本文:

虞意, 毛惠, 虞绮雯, 刘驰, 祖逸峥, 陈婉莹, 魏炜炜, 陈继明. 子宫腺肌病保守性手术的现状与未来展望[J/OL]. 中华腔镜外科杂志(电子版), 2026, 19(04): 248-253.

Yi Yu, Hui Mao, Qiwen Yu, Chi Liu, Yizheng Zu, Wanying Chen, Weiwei Wei, Jiming Chen. Current status and future perspectives of conservative surgery for adenomyosis[J/OL]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2026, 19(04): 248-253.

子宫腺肌病是育龄期女性常见的良性疾病,其特征为子宫内膜腺体和间质侵入子宫肌层,伴随周围肌层细胞增生肥大。其临床表现主要为进行性加重的痛经、月经过多、慢性盆腔痛及不孕,严重影响患者的生活质量。治疗策略主要包括药物治疗和手术治疗。对于药物治疗无效、症状严重或有生育要求的患者,手术治疗是重要的选择。根治性手术即子宫切除术虽能根治疾病,但剥夺了患者的生育功能,并给患者带来一系列生理和心理影响。因此,保留子宫的保守性手术治疗方式日益受到重视。本文旨在系统综述子宫腺肌病保守性手术治疗的最新进展,并对未来发展方向进行展望。

Adenomyosis is a common benign gynecological disease in women of reproductive age, characterized by the invasion of endometrial glands and stroma into the myometrium, accompanied by hyperplasia and hypertrophy of the surrounding myocytes. Its clinical manifestations mainly include progressively worsening dysmenorrhea, menorrhagia, chronic pelvic pain, and infertility, severely affecting patients' quality of life. Treatment strategies primarily include medical therapy and surgical treatment. For patients with severe symptoms who do not respond to medical therapy or have fertility requirements, surgical treatment is an important option. Radical surgery, i. e., hysterectomy, can cure the disease but deprives patients of fertility and brings about a series of physiological and psychological impacts. Therefore, uterus-preserving conservative surgical approaches are receiving increasing attention. This article aims to systematically review the latest advances in conservative surgical treatment of adenomyosis and provide an outlook on future directions.

[1]
Schrager S, Yogendran L, Marquez CM, et al. Adenomyosis: diagnosis and management[J]. Am Fam Physician, 2022, 105(1): 33-38.
[2]
Koh HH, Park E, Kim HS. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Genomic and Immunohistochemical Profiling with Comprehensive Clinicopathological Analysis of 17 Consecutive Cases from a Single Institution[J]. Biomedicines, 2023, 11(8): 2269.
[3]
Vannuccini S, Petraglia F. Recent advances in understanding and managing adenomyosis[J]. F1000Res, 2019, 8: F1000 Faculty Rev-283.
[4]
Antero MF, Ayhan A, Segars J, et al. Pathology and pathogenesis of adenomyosis[J]. Semin Reprod Med, 2020, 38(2-3): 157-166.
[5]
Moldassarina RS. Modern view on the diagnostics and treatment of adenomyosis[J]. Arch Gynecol Obstet, 2023, 308(1): 171-181.
[6]
Benagiano G, Habiba M, Brosens I. The pathophysiology of uterine adenomyosis: an update[J]. Fertil Steril, 2012, 98(3): 572-579.
[7]
Leyendecker G, Kunz G, Herbertz M, et al. Uterine peristaltic activity and the development of endometriosis[J]. Ann N Y Acad Sci, 2004, 1034: 338-355.
[8]
Parazzini F, Vercellini P, Panazza S, et al. Risk factors for adenomyosis[J]. Hum Reprod, 1997, 12(6): 1275-1279.
[9]
Levgur M, Abadi M, Tucker A. Adenomyosis: symptoms, histology, and pregnancy terminations[J]. Obstet Gynecol, 2000, 95(5): 688-691.
[10]
Taran F, Weaver A, Coddington C, et al. Understanding adenomyosis: a case control study[J]. Fertil Steril, 2010, 94(4): 1223-1228.
[11]
Leyendecker G, Kunz G, Noe M, et al. Endometriosis: a dysfunction and disease of the archimetra[J]. Hum Reprod Update, 1998, 4(5): 752-762.
[12]
Gargett CE, Ye L. Endometrial reconstruction from stem cells[J]. Fertil Steril, 2012, 98(1): 11-20.
[13]
Yilmaz BD, Bulun SE. Endometriosis and nuclear receptors[J]. Hum Reprod Update, 2019, 25(4): 473-485.
[14]
Bulun SE, Yildiz S, Adli M, et al. Endometriosis and adenomyosis: shared pathophysiology[J]. Fertil Steril, 2023, 119(5): 746-750.
[15]
Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis[J]. Endocr Rev, 2019, 40(4): 1048-1079.
[16]
Zhang H, Li C, Li W, et al. Research Advances in Adenomyosis-Related Signaling Pathways and Promising Targets[J]. Biomolecules, 2024, 14(11): 1402.
[17]
Selntigia A, Molinaro P, Tartaglia S, et al. Adenomyosis: An Update Concerning Diagnosis, Treatment, and Fertility[J]. J Clin Med, 2024, 13(17): 5224.
[18]
Brown HK, Stoll BS, Nicosia SV, et al. Uterine junctional zone: correlation between histologic findings and MR imaging[J]. Radiology, 1991, 179(2): 409-413.
[19]
Van den Bosch T, Dueholm M, Leone FPG, et al. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group[J]. Ultrasound Obstet Gynecol, 2015, 46(3): 284-298.
[20]
Bazot M, Daraï E. Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis[J]. Fertil Steril, 2018, 109(3): 389-397.
[21]
Harmsen MJ, Van den Bosch T, de Leeuw RA, et al. Consensus on revised definitions of Morphological Uterus Sonographic Assessment (MUSA) features of adenomyosis: results of modified Delphi procedure[J]. Ultrasound Obstet Gynecol, 2022, 60(1): 118-131.
[22]
Harmsen MJ, Trommelen LM, de Leeuw RA, et al. Uterine junctional zone and adenomyosis: comparison of MRI, transvaginal ultrasound and histology[J]. Ultrasound Obstet Gynecol, 2023, 62(1): 42-60.
[23]
Reinhold C, McCarthy S, Bret PM, et al. Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation[J]. Radiology, 1996, 199(1): 151-158.
[24]
Dueholm M, Lundorf E, Hansen ES, et al. Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis[J]. Fertil Steril, 2001, 76(3): 588-594.
[25]
Huang Y, Zhou Y, Chen H, et al. Changes of serum CA125 and PGE2 before and after high-intensity focused ultrasound combined with GnRH-a in treatment of patients with adenomyosis[J]. Open Med (Wars), 2024, 19(1): 20240928.
[26]
Tang Y, Wen MB, Xiang RM, et al. Serum CA125 as a biomarker for dysmenorrhea in adenomyosis[J]. Int J Gynaecol Obstet, 2023, 163(1): 131-139.
[27]
Khan KN, Fujishita A, Mori T. Pathogenesis of Human Adenomyosis: Current Understanding and Its Association with Infertility[J]. J Clin Med, 2022, 11(14): 4057.
[28]
Kishi Y, Suginami H, Kuramori R, et al. Four subtypes of adenomyosis assessed by magnetic resonance imaging and their specification[J]. Am J Obstet Gynecol, 2012, 207(2): 114.e1-114.e7.
[29]
Hashim HA, Elaraby S, Fouda AA, et al. The prevalence of adenomyosis in an infertile population: a cross-sectional study[J]. Reprod Biomed Online, 2020, 40(6): 842-850.
[30]
Zhao Y, Luo S, Liu Y, et al. High intensity focused ultrasound treatment for adenomyosis: comparison of efficacy based on MRI features[J]. Int J Hyperthermia, 2023, 40(1): 2197574.
[31]
Etrusco A, Barra F, Chiantera V, et al. Current Medical Therapy for Adenomyosis: From Bench to Bedside[J]. Drugs, 2023, 83(17): 1595-1611.
[32]
Englander M. Uterine Artery Embolization for the Treatment of Adenomyosis[J]. Semin Intervent Radiol, 2008, 25(4): 387-393.
[33]
Mikos T, Lioupis M, Anthoulakis C, et al. The Outcome of Fertility-Sparing and Nonfertility-Sparing Surgery for the Treatment of Adenomyosis. A Systematic Review and Meta-analysis[J]. J Minim Invasive Gynecol, 2020, 27(2): 309-331.e3.
[34]
Takeuchi H, Kitade M, Kikuchi I, et al. Laparoscopic adenomyomectomy and hysteroplasty: a novel method[J]. J Minim Invasive Gynecol, 2006, 13(2): 150-154.
[35]
Younes G, Tulandi T. Conservative Surgery for Adenomyosis and Results: A Systematic Review[J]. J Minim Invasive Gynecol, 2018, 25(2): 265-276.
[36]
Kwack JY, Seo M, Su Hong J, et al. Advanced laparoscopic adenomyomectomy technique for focal uterine adenomyosis by three-step approach[J]. JSLS, 2022, 26(4): e2022.00055.
[37]
Osada H. Uterine adenomyosis and adenomyoma: the surgical approach[J]. Fertil Steril, 2018, 109(3): 406-417.
[38]
Liu L, Wei W, Tang H, et al. Modified Laparoscopic Inverted Triangle Model for Extended Lesion Resection in the Treatment of Symptomatic Localized Adenomyosis in Women Who Have Completed Childbirth[J]. Clin Exp Obstet Gynecol, 2023, 50(9): 183.
[39]
Osada H, Silber S, Kakinuma T, et al. Surgical procedure to conserve the uterus for future pregnancy in patients suffering from massive adenomyosis[J]. Reprod Biomed Online, 2011, 22(1): 94-99.
[40]
Grimbizis GF, Mikos T, Tarlatzis B. Uterus-sparing operative treatment for adenomyosis[J]. Fertil Steril, 2014, 101(2): 472-487.e8.
[41]
Wu R, Zeng L, Hu Q, et al. Outcome of uterine functional structures protection by fertility preservative PUSH surgery in diffuse adenomyosis[J]. Hum Fertil (Camb), 2023, 26(4): 720-732.
[42]
Kuo HH, Weng CH, Jaiswal A, et al. Performing laparoscopic adenomyomectomy with the four-petal method[J]. Fertil Steril, 2020, 114(6): 1352-1354.
[43]
Givens MB, Lindheim SR, Goodman LR. New approaches in bloom: four-petal adenomyomectomy technique[J]. Fertil Steril, 2020, 114(6): 1195-1196.
[44]
Gkrozou F, Vatopoulou A, Skentou C, et al. Diagnosis and Treatment of Adenomyosis with Office Hysteroscopy—A Narrative Review of Literature[J]. Diagnostics, 2023, 13(13): 2182.
[45]
Munro MG. Endometrial ablation[J]. Best Pract Res Clin Obstet Gynaecol, 2018, 46: 120-139.
[46]
Dedes I, Kolovos G, Fruscalzo A, et al. Radiofrequency Ablation for Adenomyosis[J]. J Clin Med, 2023, 12(9): 3069.
[47]
Cho N, Lee KY, Huh J, et al. Cognitive-enhancing effects of Rhus verniciflua bark extract and its active flavonoids with neuroprotective and anti-inflammatory activities[J]. Food Chem Toxicol, 2013, 58: 355-361.
[48]
Lin XL, Hai N, Zhang J, et al. Comparison between microwave ablation and radiofrequency ablation for treating symptomatic uterine adenomyosis[J]. Int J Hyperthermia, 2020, 37(1): 151-156.
[49]
Nam JH. Pregnancy and symptomatic relief following ultrasound-guided transvaginal radiofrequency ablation in patients with adenomyosis[J]. J Obstet Gynaecol Res, 2020, 46(1): 124-132.
[50]
Stepniewska AK, Baggio S, Clarizia R, et al. Heat can treat: long-term follow-up results after uterine-sparing treatment of adenomyosis with radiofrequency thermal ablation in 60 hysterectomy candidate patients[J]. Surg Endosc, 2022, 36(8): 5803-5811.
[51]
McCausland V. The response of adenomyosis to endometrial ablation/resection[J]. Hum Reprod Update, 1998, 4(4): 350-359.
[52]
de Bruijn AM, Smink M, Lohle PNM, et al. Uterine Artery Embolization for the Treatment of Adenomyosis: A Systematic Review and Meta-Analysis[J]. J Vasc Interv Radiol, 2017, 28(12): 1629-1642.e1.
[53]
Zhang L, Rao F, Setzen R. High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility[J]. Acta Obstet Gynecol Scand, 2017, 96(6): 707-714.
[54]
Nijenhuis R, Smeets A, Morpurgo M, et al. Uterine artery embolisation for symptomatic adenomyosis with polyzene F-coated hydrogel microspheres: three-year clinical follow-up using UFS-QoL questionnaire[J]. Cardiovasc Intervent Radiol, 2015, 38(1): 65-71.
[55]
Fan TY, Zhang L, Chen W, et al. Feasibility of MRI-guided high intensity focused ultrasound treatment for adenomyosis[J]. Eur J Radiol, 2012, 81(11): 3624-3630.
[56]
Liu Y, Zhang WW, He M, et al. Adverse effect analysis of high-intensity focused ultrasound in the treatment of benign uterine diseases[J]. Int J Hyperthermia, 2018, 35(1): 56-61.
[57]
Lee JS, Hong GY, Lee KH, et al. Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid[J]. BJOG, 2017, 124(Suppl 3): 18-22.
[58]
Otonkoski S, Sainio T, Mattila S, et al. Magnetic resonance guided high intensity focused ultrasound for uterine fibroids and adenomyosis has no effect on ovarian reserve[J]. Int J Hyperthermia, 2023, 40(1): 2154575.
[59]
Ribeiro F, Ferreira H. Novel Minimally Invasive Surgical Approaches to Endometriosis and Adenomyosis: A Comprehensive Review[J]. J Clin Med, 2024, 13(22): 6844.
[60]
LeeSY, Lee SR, Song JY. Single-Port Versus Reduced-Port (1+1) Robotic Myomectomy and Hysterectomy[J]. J Clin Med, 2024, 13(21): 6563.
[61]
Jiang J, Pan Y, Yu J, et al. Laparoscopic adenomyomectomy combined with levonorgestrel-releasing intrauterine system is effective for long-term management of adenomyosis[J]. BMC Womens Health, 2024, 24(1): 28.
[62]
Gao Y, Shan S, Zhao X, et al. Clinical efficacy of adenomyomectomy using "H" type incision combined with Mirena in the treatment of adenomyosis[J]. Medicine (Baltimore), 2019, 98(11): e14579.
[63]
Ziegler N, de Wilde RL. Reduction of adhesion formation after gynaecological adhesiolysis surgery with 4DryField PH-a retrospective, controlled study with second look laparoscopies[J]. J Obstet Gynaecol, 2022, 42(4): 658-664.
[64]
Alkatout I, de Wilde RL, Herrmann J, et al. Adhesion Prevention in Gynecologic Surgery: Guidance and Clinical Experience[J]. J Clin Med, 2024, 13(24): 7517.
[65]
曹杨,孙海,朱花,等. 脐带间充质干细胞胶原支架治疗复发性宫腔粘连的Ⅰ期临床试验[J]. 干细胞研究与治疗,2018, 9(1): 192.
[1] 陈汉鑫, 赵廷虎, 岳志军, 张烨, 朱远彬, 张勇. 关节镜治疗顽固性止点性跟腱炎的临床研究[J/OL]. 中华关节外科杂志(电子版), 2026, 20(04): 510-514.
[2] 戴红梅, 李双喜, 李子禹. 我国腹腔镜胃癌手术治疗现状与未来[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(02): 103-107.
[3] 孟黄洋, 周树林, 邱江南, 程文俊. 腹膜后淋巴结清扫术在妇科恶性肿瘤中的应用进展[J/OL]. 中华腔镜外科杂志(电子版), 2026, 19(04): 215-219.
[4] 白雪峰, 熊家强, 宋锐南, 陈雨柔, 吕琼莹, 张蔚. 机器人宫颈癌根治手术的并发症防治[J/OL]. 中华腔镜外科杂志(电子版), 2026, 19(03): 132-134.
[5] 王静静, 徐亚雄, 关小明, 胡晓洁, 窦晓卫, 张春花. 达芬奇Xi-vNOTES与术锐SP-vNOTES在子宫切除术中的比较研究[J/OL]. 中华腔镜外科杂志(电子版), 2026, 19(03): 153-158.
[6] 李亚楠, 黄向华. 阴道内镜在女性生殖道畸形诊治中的应用[J/OL]. 中华腔镜外科杂志(电子版), 2026, 19(02): 77-82.
[7] 宋佳耕, 袁文翰, 郑莹. 人工智能在妇科微创手术中的应用与展望[J/OL]. 中华腔镜外科杂志(电子版), 2026, 19(01): 60-64.
[8] 李中宇, 杨谨闻, 麻勇. 微创脾部分切除术的发展现状与展望[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(04): 545-550.
[9] 牛海鹏, 王石. 脾脏肿瘤诊疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(04): 529-536.
[10] 原姚谦, 令狐恩强. 超级微创保全器官根治胃癌的临床策略[J/OL]. 中华胃肠内镜电子杂志, 2026, 13(02): 73-77.
[11] 田帅, 夏晓静, 胡肖廷, 原姚谦, 周泇言, 陈倩倩, 令狐恩强. 中国消化领域资深专家对超级微创手术(SMIS)理念的认知度与认可度及推广现状:一项全国性问卷调查[J/OL]. 中华胃肠内镜电子杂志, 2026, 13(02): 81-92.
[12] 令狐恩强. 基于超级微创手术理论再看人体生命观的解构与重建[J/OL]. 中华胃肠内镜电子杂志, 2026, 13(01): 5-9.
[13] 尚辉辉, 贾雯, 刘娇, 杨新, 王静. 两种内镜治疗方式在G1期直肠神经内分泌瘤中的疗效及预后分析[J/OL]. 中华胃肠内镜电子杂志, 2026, 13(01): 18-24.
[14] 陈倩倩, 吕昆明, 李惠凯, 令狐恩强. 超级微创阶梯式全层切除术在早期胃癌治疗的应用规范[J/OL]. 中华胃肠内镜电子杂志, 2026, 13(01): 10-12.
[15] 梁斌. 在超级微创(SMIS)理念引领下[J/OL]. 中华胃肠内镜电子杂志, 2026, 13(01): 72-72.
阅读次数
全文


摘要


AI
小
编
AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?